Paper - WANFANG MED ONLINE

You Position: Home > Paper

内皮祖细胞治疗急性肺损伤研究的进展与展望

( views:247, downloads:301 )

Author:: No author available

Journal Title:: NATIONAL MEDICAL JOURNAL OF CHINA

Issue:: 38

DOI:: 10.3760/cma.j.issn.0376-2491.2010.38.019

Key Word:: No keyword available

Abstract： @@ 急性肺损伤(acute lung injury,ALI)和急性呼吸窘迫综合征(acute respiratory distress syndrome,ARDS)是临床常见的呼吸系统急危重症.虽然随着广谱抗生素的应用和机械通气模式的改进,ALI/ARDS的治愈率有所改善,但目前总体死亡率仍高达40%[1].ALI/ARDS的早期病理改变为内皮表面受损和肺泡-毛细血管屏障破坏,因此以内皮为靶点的治疗被认为是潜在的有效方法[2].但表面活性因子、肺血管扩张剂、抗氧化剂、他汀等以内皮为靶点的药物均未能降低ALI/ARDS的死亡率,这促使研究者寻找更为有效的内皮保存与修复手段[3-4].

Reference

[1]Wolf D,Koeck R,Rumpold H,etc.CD34+/CD133- circulating endothelial precursor cells (CEP): characterization, senescence and in vivo application.[J].2006,41(6).
[2]Gupta N,Serikov V,Matthay MA,etc.Potential application of mesenchymal stem cells in acute lung injury.[J].2009,9(10).
[3]Orfanos SE,Catravas JD,Kotanidou A,etc.Endothelial pathomechanisms in acute lung injury.[J].2008,49(4).
[4]Critser PJ,Yoder MC.Endothelial colony-forming cell role in neoangiogenesis and tissue repair.[J].2010,15(1).
[5]Ishizawa K,Sasaki H,Kubo H,etc.Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: evidence that bone marrow derived cells contribute to lung repair.[J].2005,60(5).
[6]Hagensen MK,Shim J,Thim.Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis.[J].2010,121(7).
[7]Raghavendran K,Pryhuber GS,Chess PR,etc.Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.[J].2008,15(19).
[8]Nishibe T,Yasuda K,Nishibe M,etc.Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia.[J].2003,22(4).
[9]Asahara, Takayuki,Murohara, Toyoaki.Isolation of putative progenitor endothelial cells for angiogenesis.[J].1997,275(5302).
[10]Taylor WR,Brigham KL,Burnham EL,etc.Increased circulating endothelial progenitor cells are associated with survival in acute lung injury.[J].2005,172(7).
[11]Tang T,Shaked Y,Woloszynek J.Contribution of granulocyte colony-stimulating factor to the acute mobilization of endothelial precursor cells by vascular disrupting agents.[J].2009,69(19).
[12]Goldschmidt-Clermont PJ,Dong C.Endothelial progenitor cells: a promising therapeutic alternative for cardiovascular disease.[J].2007,20(2).
[13]Wirbelauer J,Speer CP.The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.[J].2009,29(Suppl.2).
[14]Lazzeri E,Romagnani P,Ronconi E,etc.The role of endothelial progenitor cells in acute kidney injury.[J].2009,27(3).
[15]Lippolt P,Arseniev L,Hornig B,etc.Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.[J].2004,364(9429).
[16]Devanesan AJ,Girn HR,Laughlan KA.Endothelial progenitor cells as a therapeutic option in peripheral arterial disease.[J].2009,38(4).
[17]Thum T,Bauersachs J.Endothelial progenitor cells as potential drug targets.[J].2005,5(4).
[18]Krenning G,Harmsen MC,van Luyn MJ.Endothelial progenitor cell-based neovascularization: implications for therapy.[J].2009,15(4).
[19]Takahashi M,Ishigatsubo Y,Izawa A.Therapeutic neovascularization by the implantation of autologous mononuclear cells in patients with connective tissue diseases.[J].2009,15(24).